Atossa Therapeutics (ATOS) EBITDA Margin (QoQ) (2012 - 2014)
Atossa Therapeutics (ATOS) EBITDA Margin (QoQ) (2012 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Atossa Therapeutics | 23.16 Mn | 23.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -2.80 Mn |
| Sep 30, 2014 | -6.25 Mn |
| Jun 30, 2014 | -2.23 Mn |
| Mar 31, 2014 | -1.08 Mn |
| Dec 31, 2013 | 561,322.00 |
| Sep 30, 2013 | -270,708.00 |
| Jun 30, 2013 | 1.23 Mn |
| Mar 31, 2013 | -1.27 Mn |
| Dec 31, 2012 | -65,643.00 |
| Sep 30, 2012 | 3.62 Mn |
| Jun 30, 2012 | 1.58 Mn |
| Mar 31, 2012 | 2.67 Mn |